Analyst Reco. Wave Life Sciences Ltd.

Equities

WVE

SG9999014716

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
6.14 ^USD	+4.42%		+31.76%	+21.58%

Apr. 30	Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency	CI
Apr. 23	Wave Life Sciences Ltd. Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mizuho Adjusts Price Target on WAVE Life Sciences to $19 From $10, Maintains Buy Rating	Mar. 12	MT
H.C. Wainwright Adjusts Price Target on WAVE Life Sciences to $15 From $8, Maintains Buy Rating	Mar. 07	MT
Leerink Partners Upgrades WAVE Life Sciences to Outperform From Market Perform, Price Target at $12	Dec. 19	MT
Raymond James Initiates WAVE Life Sciences at Outperform Rating With $7 Price Target	23-07-05	MT
Mizuho Securities Adjusts WAVE Life Sciences Price Target to $10 From $13, Maintains Buy Rating	23-05-24	MT
SVB Securities Raises Price Target on WAVE Life Sciences to $7 From $2, Maintains Market Perform Rating	22-12-14	MT
UK Unemployment Rate Expected to Increase to 5% by End of 2023	22-12-13	DJ
RBC Cuts Price Target on WAVE Life Sciences to $5 From $8, Maintains Sector Perform, Speculative Risk	22-11-11	MT
SVB Securities Adjusts Price Target on WAVE Life Sciences to $3 From $7, Maintains Market Perform Rating	22-05-13	MT
HC Wainwright Adjusts WAVE Life Sciences' Price Target to $8 from $10, Keeps Buy Rating	22-05-13	MT
Stifel Adjusts WAVE Life Sciences' Price Target to $3 From $6, Reiterates Hold Rating	22-03-04	MT
WAVE LIFE SCIENCES : Mizuho Securities Lifts Price Target on WAVE Life Sciences to $13 From $8, Citing ADAR Sales Estimates; Buy Rating Kept	21-08-12	MT
WAVE LIFE SCIENCES : Mizuho Securities Adjusts Price Target on WAVE Life Sciences to $8 From $7, Keeps Buy Rating	21-05-18	MT
WAVE LIFE SCIENCES : Mizuho Adjusts Price Target on WAVE Life Sciences to $7 From $21, Maintains Buy Rating	21-03-30	MT
WAVE LIFE SCIENCES : HC Wainwright Adjusts Price Target on WAVE Life Sciences to $10 From $20, Maintains Buy Rating	21-03-30	MT
WAVE LIFE SCIENCES : Truist Adjusts Price Target on WAVE Life Sciences to $17 From $27, Maintains Buy Rating	21-03-30	MT
WAVE LIFE SCIENCES : SVB Leerink Adjusts WAVE Life Sciences' Price Target to $7 from $10, Keeps Market Perform Rating	21-03-30	MT
-ANALYST ACTIONS : RBC Cuts Price Target on WAVE Life Sciences to $8 From $13, Maintains Sector Perform Speculative Risk	21-03-30	MT
WAVE LIFE SCIENCES : Mizuho Adjusts WAVE Life Sciences' PT to $7 From $21 on Trial Data for WVE-120102, 120101 in Huntington's Disease; Buy Rating Kept	21-03-30	MT
IONIS PHARMACEUTICALS' : Price Target From RBC Cut to $65 From $76 on Trial Discontinuation; Shares Fall Pre-Bell	21-03-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Wave Life Sciences Ltd.

Equities

WVE

SG9999014716

Analyst Reco.

Filters